Pattern recognition receptor responses in children with chronic hepatitis B virus infection.

[1]  H. Janssen,et al.  Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function , 2011, PloS one.

[2]  A. Bowie,et al.  IFI16 is an innate immune sensor for intracellular DNA , 2010, Nature Immunology.

[3]  M. Maini,et al.  Innate and Adaptive Immune Responses in Hepatitis B Virus Infection , 2010, Digestive Diseases.

[4]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[5]  Y. Li,et al.  Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. , 2010, Virology.

[6]  F. Zoulim,et al.  Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus , 2009, Hepatology.

[7]  Zhan-qing Zhang,et al.  HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. , 2009, Molecular immunology.

[8]  S. Paludan,et al.  Innate recognition of intracellular pathogens: detection and activation of the first line of defense , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[9]  Mong-Liang Chen,et al.  HBV replication is significantly reduced by IL-6 , 2009, Journal of Biomedical Science.

[10]  Richard A. Flavell,et al.  RIG-I-mediated Activation of p38 MAPK Is Essential for Viral Induction of Interferon and Activation of Dendritic Cells , 2009, Journal of Biological Chemistry.

[11]  Hong Yu,et al.  Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. , 2009, Microbes and infection.

[12]  T. Mogensen.  Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses , 2009, Clinical Microbiology Reviews.

[13]  Zhan-qing Zhang,et al.  Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. , 2008, Clinical immunology.

[14]  Jia-Jun Liu,et al.  The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B. , 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

[15]  P. Rosenthal,et al.  Hepatitis B in children. , 2008, Pediatrics in review.

[16]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[17]  R. Schneider,et al.  Tumor Necrosis Factor Activates a Conserved Innate Antiviral Response to Hepatitis B Virus That Destabilizes Nucleocapsids and Reduces Nuclear Viral DNA , 2007, Journal of Virology.

[18]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[19]  S. Riordan,et al.  Reduced Expression of Toll-Like Receptor 2 on Peripheral Monocytes in Patients with Chronic Hepatitis B , 2006, Clinical and Vaccine Immunology.

[20]  Antonio Bertoletti,et al.  The immune response during hepatitis B virus infection. , 2006, The Journal of general virology.

[21]  S. Kaneko,et al.  Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression , 2006, International journal of cancer.

[22]  S. Fan,et al.  Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[23]  P. Kremsner,et al.  Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  S. Kaneko,et al.  Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. , 2003, The American journal of pathology.

[25]  P. Tangkijvanich,et al.  Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease. , 2000, Asian Pacific journal of allergy and immunology.

[26]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[27]  T. Ishikawa,et al.  Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis , 1993, Gastroenterologia Japonica.

[28]  Y. Ni.  Natural history of hepatitis B virus infection: pediatric perspective , 2010, Journal of Gastroenterology.

[29]  Qing Liu,et al.  Detection of interleukin-6 and -12 in of hepatitis B patients and its clinical significance. , 2001, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.